Trial site
University of Texas M.D. Anderson Cancer Center
- 13running trials
- 4closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Myeloproliferative neoplasms3 trials
- Acute myeloid leukaemia2 trials
- Colorectal cancer2 trials
- Head and neck cancer2 trials
- Liver and biliary tract cancer2 trials
- Pancreatic cancer2 trials
- Sarcoma2 trials
- Triple-negative breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- and 9 more
- Phase
- Phase 15 trials
- Phase 24 trials
- Phase 33 trials
- Phase 1/22 trials
- Status
- Recruiting8 trials
- Active, not recruiting4 trials
- Completed2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Incyte Corporation2 trials
- AIDS Malignancy Consortium1 trial
- Aptose Biosciences Inc.1 trial
- Barbara Ann Karmanos Cancer Institute1 trial
- Bio-Path Holdings, Inc.1 trial
- and 11 more
Running trials
Recruiting
Recruiting
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Recruiting
Recruiting
TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma
Active, not recruiting
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
Active, not recruiting
Recruiting
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Recruiting
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Myeloproliferative neoplasms2 recruiting
- Acute myeloid leukaemia1 recruiting
- Cervical cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- HIV1 recruiting
- Liver and biliary tract cancer1 recruiting
- Ovarian cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Completed
Terminated
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026